| Date Filed | Type | Description |
| 10/05/2023 |
4
| Thompson Elizabeth H.Z. (Director) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 31,000 options to buy
@ $6.71, valued at
$208k
|
|
| 10/05/2023 |
3
| Thompson Elizabeth H.Z. (Director) has filed a Form 3 on IGM Biosciences, Inc. |
| 10/03/2023 |
4
| Redmile Group, LLC (Director) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 492 shares
@ $0 |
|
| 10/03/2023 |
4
| Lee Michael Stewart (Director) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 492 shares
@ $0 |
|
| 10/03/2023 |
4
| Gauthier George (Chief Commercial Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Sold 935 shares
@ $7.9463, valued at
$7.4k
|
|
| 10/03/2023 |
4
| Topsoe Jakob Haldor (10% Owner) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 492 shares
@ $0 |
|
| 10/03/2023 |
4
| Topsoe Christina Teng (10% Owner) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 738 shares
@ $0 |
|
| 10/03/2023 |
4
| LOBERG MICHAEL D (Director) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 1,138 shares
@ $0 |
|
| 10/03/2023 |
4
| BEHRENS M KATHLEEN (Director) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 800 shares
@ $0 |
|
| 10/03/2023 |
4
| BAKER BROS. ADVISORS LP (Director) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 554 shares
@ $0 |
|
| 07/05/2023 |
4
| LOBERG MICHAEL D (Director) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 1,138 shares
@ $0 |
|
| 07/05/2023 |
4
| Gauthier George (Chief Commercial Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Sold 936 shares
@ $9.4209, valued at
$8.8k
|
|
| 07/05/2023 |
4
| Topsoe Christina Teng (10% Owner) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Bought 3,000 shares
@ $9.3189, valued at
$28k
Granted 738 shares
@ $0 |
|
| 07/05/2023 |
4
| BEHRENS M KATHLEEN (Director) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 800 shares
@ $0 |
|
| 07/05/2023 |
4
| BAKER BROS. ADVISORS LP (Director) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 554 shares
@ $0 |
|
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Redmile Group, LLC (Director) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Sold 80,423 shares
@ $9.42, valued at
$757.6k
Bought 80,423 shares
@ $9.42, valued at
$757.6k
Disposed of 54,740 shares
@ $9.42, valued at
$515.7k
Acquired 54,740 shares
@ $9.42, valued at
$515.7k
Granted 492 shares
@ $0 |
|
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2023 |
4
| Redmile Group, LLC (Director) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 2,812,500 options to buy
@ $8, valued at
$22.5M
|
|
| 06/28/2023 |
4
| Topsoe Jakob Haldor (10% Owner) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Bought 1,687,500 options to buy
@ $8, valued at
$13.5M
|
|
| 06/28/2023 |
4
| Topsoe Christina Teng (10% Owner) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Bought 1,687,500 options to buy
@ $8, valued at
$13.5M
|
|
| 06/28/2023 |
4
| Topsoe Holding A/S (10% Owner) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Bought 1,687,500 options to buy
@ $8, valued at
$13.5M
|
|
| 06/28/2023 |
4
| BEHRENS M KATHLEEN (Director) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Bought 112,500 shares
@ $8, valued at
$900k
|
|
| 06/28/2023 |
4
| BAKER BROS. ADVISORS LP (Director) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Bought 413,175 options to buy
@ $8, valued at
$3.3M
Bought 5,211,825 options to buy
@ $8, valued at
$41.7M
|
|
| 05/25/2023 |
4
| Takimoto Chris H (Chief Medical Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 962 shares
@ $11.71, valued at
$11.3k
Sold 1,244 shares
@ $12.3005, valued at
$15.3k
Sold 15 shares
@ $13.005, valued at
$195.1 |
|
| 05/25/2023 |
4
| Tahir Misbah (CFO) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 398 shares
@ $11.71, valued at
$4.7k
Sold 1,244 shares
@ $12.3005, valued at
$15.3k
Sold 15 shares
@ $13.005, valued at
$195.1 |
|
| 05/25/2023 |
4
| Schwarzer Fred (CEO and President) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 960 shares
@ $11.71, valued at
$11.2k
Sold 1,244 shares
@ $12.3005, valued at
$15.3k
Sold 15 shares
@ $13.005, valued at
$195.1 |
|
| 05/25/2023 |
4
| Keyt Bruce (Chief Scientific Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 960 shares
@ $11.71, valued at
$11.2k
Sold 970 shares
@ $12.3005, valued at
$11.9k
Sold 12 shares
@ $13.005, valued at
$156.1 |
|
| 05/25/2023 |
4
| Gauthier George (Chief Commercial Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Sold 1,244 shares
@ $12.3005, valued at
$15.3k
Sold 15 shares
@ $13.005, valued at
$195.1 |
|
| 05/25/2023 |
4
| Decker Lisa Lynn (Chief Business Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 961 shares
@ $11.71, valued at
$11.3k
Sold 1,244 shares
@ $12.3005, valued at
$15.3k
Sold 15 shares
@ $13.005, valued at
$195.1 |
|
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|